company background image
300573 logo

Shenyang Xingqi PharmaceuticalLtd SZSE:300573 Stock Report

Last Price

CN¥81.64

Market Cap

CN¥15.0b

7D

-14.6%

1Y

-13.0%

Updated

02 Sep, 2024

Data

Company Financials +

Shenyang Xingqi Pharmaceutical Co.,Ltd.

SZSE:300573 Stock Report

Market Cap: CN¥15.0b

300573 Stock Overview

Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.

300573 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth6/6
Past Performance6/6
Financial Health6/6
Dividends2/6

Shenyang Xingqi Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shenyang Xingqi PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥81.64
52 Week HighCN¥214.36
52 Week LowCN¥83.73
Beta-0.033
11 Month Change-32.91%
3 Month Change-57.81%
1 Year Change-13.04%
33 Year Change44.17%
5 Year Change82.56%
Change since IPO2,053.63%

Recent News & Updates

With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

Aug 19
With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

Recent updates

With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

Aug 19
With EPS Growth And More, Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Makes An Interesting Case

What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash

Jul 24
What You Can Learn From Shenyang Xingqi Pharmaceutical Co.,Ltd.'s (SZSE:300573) P/S After Its 27% Share Price Crash

Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Jun 28
Does Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Have A Healthy Balance Sheet?

Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00

May 21
Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Is Increasing Its Dividend To CN¥3.00

After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar

May 10
After Leaping 31% Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Shares Are Not Flying Under The Radar

We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease

May 07
We Ran A Stock Scan For Earnings Growth And Shenyang Xingqi PharmaceuticalLtd (SZSE:300573) Passed With Ease

Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump

Mar 15
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SZSE:300573) Looks Just Right With A 26% Price Jump

Shareholder Returns

300573CN PharmaceuticalsCN Market
7D-14.6%1.3%1.5%
1Y-13.0%-11.5%-18.8%

Return vs Industry: 300573 underperformed the CN Pharmaceuticals industry which returned -11.5% over the past year.

Return vs Market: 300573 exceeded the CN Market which returned -18.8% over the past year.

Price Volatility

Is 300573's price volatile compared to industry and market?
300573 volatility
300573 Average Weekly Movement7.6%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement5.6%
10% most volatile stocks in CN Market8.9%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 300573's share price has been volatile over the past 3 months.

Volatility Over Time: 300573's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
19771,995E. Gaowww.sinqi.com

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company offers corneal, anti-bacteria, artificial tears, anti-inflammation, anti-allergic, mydriactics, anti-fatigue, and dry eye treatment products.

Shenyang Xingqi Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Shenyang Xingqi PharmaceuticalLtd's earnings and revenue compare to its market cap?
300573 fundamental statistics
Market capCN¥15.02b
Earnings (TTM)CN¥321.60m
Revenue (TTM)CN¥1.67b

44.3x

P/E Ratio

8.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300573 income statement (TTM)
RevenueCN¥1.67b
Cost of RevenueCN¥372.17m
Gross ProfitCN¥1.30b
Other ExpensesCN¥980.12m
EarningsCN¥321.60m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.84
Gross Margin77.77%
Net Profit Margin19.21%
Debt/Equity Ratio16.7%

How did 300573 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

144%

Payout Ratio